Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma

Koji Yamaguchi, Kenji Nakano, Eishi Nagai, Kazuo Chijiiwa, Moritoshi Kinoshita, Masayuki Ohta, Masao Tanaka

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background/Aims: The differentiation between benign and malignant jaundice is sometimes difficult even with modern diagnostic modalities. With recent advances in molecular biology, Ki-ras point mutation in codon 12 and p53 mutation have been reported as novel biomarkers of hepatobiliary and pancreatic carcinoma. The purpose of this study was to compare exfoliative bile cytology and biomarkers of the bile in patients with hepatobiliary and pancreatic diseases. Methodology: Cytologic examination and novel biomarkers, point mutations of codon 12 of Ki-ras and p53 mutations, were examined in the biliary tract bile aspirated through percutaneous transhepatic biliary drainage (PTBD) tube in 30 Japanese patients with benign and malignant hepatobiliary and pancreatic diseases. Results: Sensitivity of the exfoliative bile cytology for malignant conditions was 31% and specificity 100%, while sensitivity of molecular markers of the bile was 25% and specificity 93%. When the cytologic examination and genetic study were in conjunction, sensitivity increased to 50% and specificity remained 93%. Conclusions: These findings suggest that genetic examinations of the bile, when used in conjunction with cytology, may improve the diagnostic yield for suspected malignant tumors of the hepatobiliary and pancreatic system.

Original languageEnglish
Pages (from-to)713-718
Number of pages6
JournalHepato-gastroenterology
Volume52
Issue number63
Publication statusPublished - May 1 2005

Fingerprint

Bile
Codon
Cell Biology
Biomarkers
Mutation
Pancreatic Diseases
Point Mutation
Biliary Tract
Jaundice
Pancreatic Carcinoma
Molecular Biology
Drainage
Neoplasms

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Yamaguchi, K., Nakano, K., Nagai, E., Chijiiwa, K., Kinoshita, M., Ohta, M., & Tanaka, M. (2005). Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma. Hepato-gastroenterology, 52(63), 713-718.

Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma. / Yamaguchi, Koji; Nakano, Kenji; Nagai, Eishi; Chijiiwa, Kazuo; Kinoshita, Moritoshi; Ohta, Masayuki; Tanaka, Masao.

In: Hepato-gastroenterology, Vol. 52, No. 63, 01.05.2005, p. 713-718.

Research output: Contribution to journalArticle

Yamaguchi, K, Nakano, K, Nagai, E, Chijiiwa, K, Kinoshita, M, Ohta, M & Tanaka, M 2005, 'Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma', Hepato-gastroenterology, vol. 52, no. 63, pp. 713-718.
Yamaguchi, Koji ; Nakano, Kenji ; Nagai, Eishi ; Chijiiwa, Kazuo ; Kinoshita, Moritoshi ; Ohta, Masayuki ; Tanaka, Masao. / Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma. In: Hepato-gastroenterology. 2005 ; Vol. 52, No. 63. pp. 713-718.
@article{d6bfee9834b74e6c82fc8c93978af314,
title = "Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma",
abstract = "Background/Aims: The differentiation between benign and malignant jaundice is sometimes difficult even with modern diagnostic modalities. With recent advances in molecular biology, Ki-ras point mutation in codon 12 and p53 mutation have been reported as novel biomarkers of hepatobiliary and pancreatic carcinoma. The purpose of this study was to compare exfoliative bile cytology and biomarkers of the bile in patients with hepatobiliary and pancreatic diseases. Methodology: Cytologic examination and novel biomarkers, point mutations of codon 12 of Ki-ras and p53 mutations, were examined in the biliary tract bile aspirated through percutaneous transhepatic biliary drainage (PTBD) tube in 30 Japanese patients with benign and malignant hepatobiliary and pancreatic diseases. Results: Sensitivity of the exfoliative bile cytology for malignant conditions was 31{\%} and specificity 100{\%}, while sensitivity of molecular markers of the bile was 25{\%} and specificity 93{\%}. When the cytologic examination and genetic study were in conjunction, sensitivity increased to 50{\%} and specificity remained 93{\%}. Conclusions: These findings suggest that genetic examinations of the bile, when used in conjunction with cytology, may improve the diagnostic yield for suspected malignant tumors of the hepatobiliary and pancreatic system.",
author = "Koji Yamaguchi and Kenji Nakano and Eishi Nagai and Kazuo Chijiiwa and Moritoshi Kinoshita and Masayuki Ohta and Masao Tanaka",
year = "2005",
month = "5",
day = "1",
language = "English",
volume = "52",
pages = "713--718",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "63",

}

TY - JOUR

T1 - Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma

AU - Yamaguchi, Koji

AU - Nakano, Kenji

AU - Nagai, Eishi

AU - Chijiiwa, Kazuo

AU - Kinoshita, Moritoshi

AU - Ohta, Masayuki

AU - Tanaka, Masao

PY - 2005/5/1

Y1 - 2005/5/1

N2 - Background/Aims: The differentiation between benign and malignant jaundice is sometimes difficult even with modern diagnostic modalities. With recent advances in molecular biology, Ki-ras point mutation in codon 12 and p53 mutation have been reported as novel biomarkers of hepatobiliary and pancreatic carcinoma. The purpose of this study was to compare exfoliative bile cytology and biomarkers of the bile in patients with hepatobiliary and pancreatic diseases. Methodology: Cytologic examination and novel biomarkers, point mutations of codon 12 of Ki-ras and p53 mutations, were examined in the biliary tract bile aspirated through percutaneous transhepatic biliary drainage (PTBD) tube in 30 Japanese patients with benign and malignant hepatobiliary and pancreatic diseases. Results: Sensitivity of the exfoliative bile cytology for malignant conditions was 31% and specificity 100%, while sensitivity of molecular markers of the bile was 25% and specificity 93%. When the cytologic examination and genetic study were in conjunction, sensitivity increased to 50% and specificity remained 93%. Conclusions: These findings suggest that genetic examinations of the bile, when used in conjunction with cytology, may improve the diagnostic yield for suspected malignant tumors of the hepatobiliary and pancreatic system.

AB - Background/Aims: The differentiation between benign and malignant jaundice is sometimes difficult even with modern diagnostic modalities. With recent advances in molecular biology, Ki-ras point mutation in codon 12 and p53 mutation have been reported as novel biomarkers of hepatobiliary and pancreatic carcinoma. The purpose of this study was to compare exfoliative bile cytology and biomarkers of the bile in patients with hepatobiliary and pancreatic diseases. Methodology: Cytologic examination and novel biomarkers, point mutations of codon 12 of Ki-ras and p53 mutations, were examined in the biliary tract bile aspirated through percutaneous transhepatic biliary drainage (PTBD) tube in 30 Japanese patients with benign and malignant hepatobiliary and pancreatic diseases. Results: Sensitivity of the exfoliative bile cytology for malignant conditions was 31% and specificity 100%, while sensitivity of molecular markers of the bile was 25% and specificity 93%. When the cytologic examination and genetic study were in conjunction, sensitivity increased to 50% and specificity remained 93%. Conclusions: These findings suggest that genetic examinations of the bile, when used in conjunction with cytology, may improve the diagnostic yield for suspected malignant tumors of the hepatobiliary and pancreatic system.

UR - http://www.scopus.com/inward/record.url?scp=20644467486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20644467486&partnerID=8YFLogxK

M3 - Article

C2 - 15966189

AN - SCOPUS:20644467486

VL - 52

SP - 713

EP - 718

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 63

ER -